Ignite Creation Date:
2024-05-06 @ 6:51 PM
Last Modification Date:
2024-10-26 @ 2:56 PM
Study NCT ID:
NCT05815186
Status:
WITHDRAWN
Last Update Posted:
2024-03-29
First Post:
2023-04-04
Brief Title:
Ladarixin With Sotorasib in Advanced NSCLC - Phase II
Sponsor:
NYU Langone Health
Organization:
NYU Langone Health
Organization Data
Organization:
NYU Langone Health
Class:
OTHER
Study ID:
22-00959-2
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
NYU Langone Health
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None